Floatz logo

Vinorelbine

Invasive Breast Cancer

Massachusetts General HospitalPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

14 Active assets in the Invasive Breast Cancer cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3BB
TAMOXIFEN
University of California, San Francisco
Phase 2BB
Inno-206
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3BB
Atezolizumab
Fondazione Michelangelo
Phase 3B
Mometasone
Memorial Sloan Kettering Cancer Center
Phase 3B

View all 26 →

Same molecule, other indications

Vinorelbine is also rated in:

HER2 positive breast carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →
Recurrent Breast CarcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →